December 15, 2023

2 minute read

Amide Technologies Revolutionizes Peptide Synthesis with Novel Manufacturing Platform and Secures $16.5M in Funding

Key Highlights Amide Technologies announces commercialization of a novel peptide manufacturing platform, significantly advancing the synthesis of long…

byChris-Anne Roque

December 15, 2023

1 minute read

Parse Biosciences Secures $50 Million in Series C Financing and Debt Facility to Propel Single Cell Sequencing Innovations

Key Highlights $50 million raised in Series C equity round and debt facility, led by Soleus Capital, with notable…

byChris-Anne Roque

December 15, 2023

1 minute read

Lisa Alderson Takes the Helm as CEO of Adela, Inc. to Advance Cancer Detection Technology

Key Highlights Lisa Alderson appointed as CEO of Adela, Inc. for her extensive experience in healthcare and genomics, including…

byChris-Anne Roque

December 15, 2023

1 minute read

John Asalone Appointed CEO of Amino Health, Succeeding Founder David Vivero

Key Highlights John Asalone appointed as CEO of Amino Health, succeeding David Vivero, who transitions to Chairman. Asalone…

byChris-Anne Roque

December 15, 2023

1 minute read

Encellin Secures $9.9M in Funding to Advance Revolutionary EnCRT for Type 1 Diabetes

Key Highlights $9.9M financing round led by Khosla Ventures, with Y Combinator’s participation. Encellin’s EnCRT aims to transform T1D treatment with…

byChris-Anne Roque

December 15, 2023

Day: December 15, 2023

Amide Technologies Revolutionizes Peptide Synthesis with Novel Manufacturing Platform and Secures $16.5M in Funding

Parse Biosciences Secures $50 Million in Series C Financing and Debt Facility to Propel Single Cell Sequencing Innovations

Lisa Alderson Takes the Helm as CEO of Adela, Inc. to Advance Cancer Detection Technology

John Asalone Appointed CEO of Amino Health, Succeeding Founder David Vivero

Encellin Secures $9.9M in Funding to Advance Revolutionary EnCRT for Type 1 Diabetes